These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2135404

  • 1. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M.
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [Abstract] [Full Text] [Related]

  • 2. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K.
    Cancer Res; 1993 Jan 01; 53(1):106-11. PubMed ID: 8093229
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.
    Cancer Res; 1997 Oct 15; 57(20):4557-63. PubMed ID: 9377569
    [Abstract] [Full Text] [Related]

  • 4. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb 15; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 5. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 6. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG, Holscher M, Urdal D.
    J Immunol; 1985 Aug 15; 135(2):1145-52. PubMed ID: 2409140
    [Abstract] [Full Text] [Related]

  • 7. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 15; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H, Sun S, Iijima K, Gross MD.
    Nutr Cancer; 2000 Aug 15; 36(1):59-65. PubMed ID: 10798217
    [Abstract] [Full Text] [Related]

  • 9. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
    Ishikawa S, Tachibana T.
    Jpn J Cancer Res; 1986 Sep 15; 77(9):931-40. PubMed ID: 2945807
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor cytostatic mechanism and delayed-type hypersensitivity against a syngeneic murine tumor. Comparison between neonatally thymectomized mice and congenitally athymic nude mice.
    Mitani M, Mori K, Himeno K, Nomoto K.
    J Immunol; 1989 Mar 15; 142(6):2148-54. PubMed ID: 2493508
    [Abstract] [Full Text] [Related]

  • 11. [Immunological response in cryo-immunotherapy of malignant tumors--the mechanism of the rise and fall of NK activity and cytotoxic T lymphocytes after inoculation of Cryo-destructed Meth A cells].
    Nakazawa M.
    Osaka Daigaku Shigaku Zasshi; 1985 Jun 15; 30(1):60-86. PubMed ID: 3878396
    [No Abstract] [Full Text] [Related]

  • 12. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Ikegami H, Kurimoto M.
    Anticancer Res; 1998 Jun 15; 18(6A):4267-74. PubMed ID: 9891477
    [Abstract] [Full Text] [Related]

  • 13. [Effects of levamisole on methylcholanthrene-induced tumor. II. Potentiation of cytotoxic T-cell activities].
    Gomi K, Morimoto M, Nomoto K.
    Gan To Kagaku Ryoho; 1982 Jul 15; 9(7):1269-76. PubMed ID: 6985196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K, Morimoto M, Nomoto K.
    Cancer Res; 1982 Oct 15; 42(10):4197-202. PubMed ID: 6980702
    [Abstract] [Full Text] [Related]

  • 16. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M, Matsumoto T, Mori K, Miake S, Himeno K, Nomoto K.
    J Clin Lab Immunol; 1985 Oct 15; 18(2):97-101. PubMed ID: 3935795
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S, Yamamoto H, Fujii Y, Arai S.
    Cancer Res; 1986 Nov 15; 46(11):5548-52. PubMed ID: 2428480
    [Abstract] [Full Text] [Related]

  • 18. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K, Barth RF, Wilkie N, Lang JC, Oda Y, Kikuchi H, Everson MP, Lotze MT.
    Cancer Gene Ther; 1995 Jun 15; 2(2):113-24. PubMed ID: 7621259
    [Abstract] [Full Text] [Related]

  • 19. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T.
    Gan To Kagaku Ryoho; 1986 Mar 15; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [Abstract] [Full Text] [Related]

  • 20. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K, Morimoto M, Nomoto K.
    Gan To Kagaku Ryoho; 1982 Jul 15; 9(7):1262-8. PubMed ID: 7184454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.